Medications for Threatened Abortion
For a hemodynamically stable 5-week primigravida with threatened abortion (vaginal bleeding with closed cervix and viable fetus), there is no evidence-based medication that improves pregnancy outcomes—management is expectant with supportive care only. 1
Primary Management Approach
Expectant management is the standard of care for threatened abortion. The key interventions are:
- No pharmacologic therapy has proven efficacy in preventing progression to spontaneous abortion in threatened abortion cases 1
- Bed rest does not improve outcomes and should not be routinely recommended 1
- Progesterone supplementation has insufficient evidence to support its routine use in threatened abortion 1
Diagnostic Confirmation Required
Before initiating any management, confirm the diagnosis:
- Transvaginal ultrasound is the diagnostic method of choice to confirm fetal viability and rule out ectopic pregnancy 2
- Serial β-hCG measurements may be needed if ultrasound findings are indeterminate, with levels that should rise appropriately in viable pregnancy 3
- Do not delay ultrasound based on β-hCG levels below a discriminatory threshold, as ectopic pregnancies can present at almost any β-hCG level 2
Critical Medication Consideration: Rh Immunoglobulin
The only medication with a clear indication in threatened abortion management is:
- Anti-D immunoglobulin (50 μg) should be administered to all Rh-negative women with threatened abortion, particularly if bleeding is more than spotting 2
- Fetomaternal hemorrhage occurs in 48% of threatened abortion cases, making prophylaxis essential to prevent Rh alloimmunization 2
- Administer within 72 hours of presentation for optimal efficacy 2
Nuance in Rh Immunoglobulin Use
There is some divergence in guideline recommendations:
- The American College of Emergency Physicians recommends administration in threatened abortion with viable fetus, especially with more than spotting 2
- The American College of Obstetricians and Gynecologists notes no evidence-based recommendation exists specifically for threatened abortion with a viable fetus, and many physicians do not treat when there is a live embryo 2
- Given the catastrophic consequences of Rh alloimmunization and the 11% incidence of fetomaternal hemorrhage, administration is reasonable even with a viable fetus 2
Medications to Avoid
Do NOT prescribe the following in threatened abortion:
- Folic acid supplementation beyond routine prenatal vitamins has no proven benefit specific to threatened abortion 4
- Uterine sedatives (tocolytics) are not indicated and lack evidence in threatened abortion 4
- Hormonal treatment (progesterone) has insufficient evidence to support routine use 1
Common Pitfall: Inappropriate Progesterone Use
While some older studies suggested benefit from progesterone or "uterine sedatives," modern evidence does not support their routine use 1. The natural history of threatened abortion is determined primarily by fetal chromosomal status—approximately 50-60% of spontaneous abortions are due to chromosomal abnormalities that no medication can prevent 5.
Follow-Up and Monitoring
Serial ultrasound examinations should be performed to assess fetal growth and development in cases where pregnancy continues 2
Repeat β-hCG in 48 hours if initial ultrasound is indeterminate, looking for appropriate rise (should increase by at least 53% in 48 hours in viable pregnancy) 3
Red Flags Requiring Immediate Intervention
Watch for signs that threatened abortion is progressing to inevitable or incomplete abortion:
- Hemodynamic instability (hypotension, tachycardia) requires immediate surgical evaluation 3
- Heavy bleeding (soaking more than one pad per hour) may indicate progression 1
- Cervical dilation on examination indicates inevitable abortion, not threatened abortion 3
- Signs of infection (fever, purulent discharge, uterine tenderness) require immediate antibiotics and urgent evacuation 2
Key Takeaway
The management of threatened abortion is primarily expectant, not pharmacologic. The only medication with clear indication is anti-D immunoglobulin for Rh-negative women. Avoid the temptation to prescribe progesterone, bed rest, or other interventions that lack evidence of benefit. Focus instead on confirming viability, ruling out ectopic pregnancy, and providing appropriate Rh prophylaxis when indicated.